In a groundbreaking shift towards advancing medical research, the technology giant Salesforce, renowned for its cloud-based sales software and ownership of Slack, embarked on an innovative project known as ProGen. This ambitious venture aimed to harness the power of generative AI for the design of proteins, potentially transforming the landscape of medical treatment discovery by … Continue reading Using AI, Profluent, fueled by Salesforce research and Jeff Dean’s backing, is on a quest to find new medicines